ID
37903
Beskrivning
Study ID: 105036 Clinical Study ID: 105036 Study Title: A single-blind, randomized, placebo-controlled study to investigate the safety, tolerability, and potential effects on betamethasone pharmacokinetics of a co-administered infusion of GSK221149A in healthy female subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: betamethasone Trade Name: Retosiban Study Indication: Women's Health & Pregnancy - Other, pre-term labour
Nyckelord
Versioner (1)
- 2019-08-29 2019-08-29 -
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
29 augusti 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Betamethasone pharmacokinetics of a co-administered infusion of GSK221149A; 105036
Similar models
Study Conclusion
- StudyEvent: ODM
C1707478 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0040223 (UMLS CUI [1,4])
C2349954 (UMLS CUI [1,2])
C2349954 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,3])
C2349954 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,3])
C1706256 (UMLS CUI [1,2])
C1519316 (UMLS CUI [1,3])
C1707478 (UMLS CUI [1,2])
C0442603 (UMLS CUI [1,3])
C1707478 (UMLS CUI [1,2])
C0442603 (UMLS CUI [1,3])
Inga kommentarer